Related Experiment Video
Updated: May 4, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions
Jiyoung Lee1, Jinho Lee, Kevin S Farquhar
1Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637.
Abstract:
The sources and consequences of nongenetic variability in metastatic progression are largely unknown. To address these questions, we characterized a transcriptional regulatory network for the metastasis suppressor Raf kinase inhibitory protein (RKIP). We previously showed that the transcription factor BACH1 is negatively regulated by RKIP and promotes breast cancer metastasis. Here we demonstrate that BACH1 acts in a double-negative (overall positive) feedback loop to inhibit RKIP transcription in breast cancer cells. BACH1 also negatively regulates its own transcription. Analysis of the BACH1 network reveals the existence of an inverse relationship between BACH1 and RKIP involving both monostable and bistable transitions that can potentially give rise to nongenetic variability. Single-cell analysis confirmed monostable and bistable-like behavior. Treatment with histone deacetylase inhibitors or depletion of the polycomb repressor enhancer of zeste homolog 2 altered relative RKIP and BACH1 levels in a manner consistent with a prometastatic state. Together, our results suggest that the mutually repressive relationship between metastatic regulators such as RKIP and BACH1 can play a key role in determining metastatic progression in cancer.
Insights
Cancer metastasis can be influenced by non-genetic factors. This study reveals a feedback loop between BACH1 and RKIP, impacting breast cancer progression and variability.
Area of Science:
- Molecular Biology
- Cancer Research
- Systems Biology
Background:
- Nongenetic variability significantly influences metastatic progression, but its sources remain largely unknown.
- Raf kinase inhibitory protein (RKIP) is a known metastasis suppressor.
- The transcription factor BACH1 promotes breast cancer metastasis and is negatively regulated by RKIP.
Purpose of the Study:
- To characterize the transcriptional regulatory network of RKIP.
- To elucidate the role of BACH1 in regulating RKIP and its impact on metastatic progression.
- To investigate the mechanisms underlying nongenetic variability in cancer metastasis.
Main Methods:
- Transcriptional regulatory network analysis of RKIP and BACH1.
- Investigation of feedback loops involving BACH1 and RKIP.
- Single-cell analysis to confirm network dynamics.
- Experimental manipulation using histone deacetylase inhibitors and polycomb repressor depletion.
Main Results:
- BACH1 forms a double-negative feedback loop inhibiting RKIP transcription in breast cancer cells.
- BACH1 also negatively autoregulates its own transcription.
- An inverse relationship between BACH1 and RKIP, exhibiting monostable and bistable transitions, was identified, contributing to nongenetic variability.
- Single-cell analyses confirmed monostable and bistable-like behaviors.
- Modulation of histone deacetylase inhibitors or enhancer of zeste homolog 2 led to a prometastatic state.
Conclusions:
- The mutually repressive relationship between RKIP and BACH1 is a key driver of nongenetic variability and metastatic progression in cancer.
- Understanding these regulatory networks offers potential therapeutic targets for controlling cancer metastasis.
- Nongenetic mechanisms play a critical role in the complex process of cancer metastasis.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cancer

